The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma episode artwork

EPISODE · May 14, 2012 · 6 MIN

The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma

from Journal of Clinical Oncology (JCO) Podcast

This podcast will provide a critical evaluation of the combination of bortezomib, thalidomide, and dexamethasone in relapsed multiple myeloma

Episode metadata supplied by the publisher feed · Published May 14, 2012

Embed this episode

NOW PLAYING

The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma

0:00 6:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 6 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on May 14, 2012.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!